Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cells|March 1, 2020
SHH Signaling Pathway Drives Pediatric Bone Sarcoma ProgressionFrédéric Lézot, Isabelle Corre, Sarah Morice, et al.
Biomolecules|August 30, 2020
Antagonistic Functions of Connexin 43 during the Development of Primary or Secondary Bone TumorsJulie Talbot, Maryne Dupuy, Sarah Morice, et al.
Cancers|March 14, 2020
Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?Sarah Morice, Geoffroy Danieau, Françoise Rédini, et al.
International Journal of Molecular Sciences|August 3, 2019
New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?Geoffroy Danieau, Sarah Morice, Françoise Rédini, et al.
Journal of Cellular Physiology|April 4, 2017
Connexin43 intercellular communication drives the early differentiation of human bone marrow stromal cells into osteoblastsJulie Talbot, Régis Brion, Audrey Lamora, et al.
Molecular Cancer Therapeutics|March 12, 2024
Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent ChemosensitizerSara G Danielli, Jakob Wurth, Sarah Morice, et al.
Cancers|January 9, 2021
The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor GrowthSarah Morice, Mathilde Mullard, Regis Brion, et al.
Frontiers in Oncology|November 12, 2021
Involvement of the TGF-β Signaling Pathway in the Development of YAP-Driven Osteosarcoma Lung MetastasisSarah Morice, Geoffroy Danieau, Robel Tesfaye, et al.
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
ICG-001, an Inhibitor of the β-Catenin and cAMP Response Element-Binding Protein Dependent Gene Transcription, Decreases Proliferation but Enhances Migration of Osteosarcoma CellsGeoffroy Danieau, Sarah Morice, Sarah Renault, et al.
Cells|September 28, 2021
Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619Mélanie Lavaud, Mathilde Mullard, Robel Tesfaye, et al.
Pageof 2